Deep Learning for Patient-Specific Quality Assurance: Predicting Gamma Passing Rates for IMRT Based on Delivery Fluence Informed by log Files.

Journal: Technology in cancer research & treatment
PMID:

Abstract

In this study, we propose a deep learning-based approach to predict Intensity-modulated radiation therapy (IMRT) quality assurance (QA) gamma passing rates using delivery fluence informed by log files. A total of 112 IMRT plans for chest cancers were planned and measured by portal dosimetry equipped on TrueBeam linac. The convolutional neural network (CNN) based learning model was trained using delivery fluence as inputs and gamma passing rates (GPRs) of 4 different criteria (3%/3 mm, 2%/3 mm, 3%/2 mm, and 2%/2 mm) as outputs. Model performance for both validation and test sets was assessed using mean absolute error (MAE), mean squared error (MSE), root MSE (RMSE), Spearman rank correlation coefficients (Sr), and Determination coefficient () between the measured and predicted GPR values. In the test set, the MAE of the prediction model were 0.402, 0.511, 1.724, and 2.530, the MSE were 0.640, 0.986, 6.654, and 9.508, the RMSE were 0.800, 0.993, 2.580, and 3.083, the Sr were 0.643, 0.684, 0.821, and 0.824 ( < .001) and the were 0.4110, 0.4666, 0.6677, and 0.6769 for 3%/3 mm, 3%/2 mm, 2%/3 mm, and 2%/2 mm, respectively. The MAE and RMSE of the prediction model decreased with stricter gamma criteria while the Sr and between measured and predicted GPR values increased. The CNN prediction model based on delivery fluence informed by log files could accurately predict IMRT QA passing rates for different gamma criteria. It could reduce QA workload and improve efficiency in pretreatment QA. Our results suggest that the CNN prediction model based on delivery fluence informed by log files may be a promising tool for the gamma evaluation of IMRT QA.

Authors

  • Ying Huang
    Department of Otolaryngology, Head and Neck Surgery, Affiliated Hospital of Southwest Medical University Luzhou, Sichuan, China.
  • Yifei Pi
    Department of Radiation Oncology, 191599The First Affiliated Hospital of Zhengzhou University, Henan, China.
  • Kui Ma
    Department of Neurosurgery, Anhui No. 2 Provincial People's Hospital, Hefei, Anhui, China.
  • Xiaojuan Miao
    The General Hospital of Western Theater Command PLA, Chengdu, China.
  • Sichao Fu
    The General Hospital of Western Theater Command PLA, Chengdu, China.
  • Zhen Zhu
    71141Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Yifan Cheng
    Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, China.
  • Zhepei Zhang
    71141Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Hua Chen
    Management College, Beijing Union University, Beijing, China.
  • Hao Wang
    Department of Cardiology, Second Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Hengle Gu
    Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Yan Shao
    Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Yanhua Duan
    Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Aihui Feng
    Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Weihai Zhuo
    Key Lab of Nuclear Physics & Ion-Beam Application (MOE), 12478Fudan University, Shanghai, China.
  • Zhiyong Xu